IL2 and cancer: Table S3 shows the result of pathway analysis for these genes indicating their functional involvement with regulation of prominent cancer and inflammatory pathways such as interleukin (IL)2, epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), p53, tyrosine receptor kinase (TRK)/mitogen activated protein kinase (MAPK), androgen receptor (AR), focal adhesion kinase (FAK), mammalian target of rapamycin (mTOR) and IL6.